Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Economy & Forex  >  All News

News : Economy & Forex

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors 
All NewsEconomyCurrencies / ForexCryptocurrenciesEconomic EventsPress releases

J&J unit to pay $360 million to U.S. to resolve charity kickback probe

share with twitter share with LinkedIn share with facebook
share via e-mail
0
12/06/2018 | 11:17pm CET
Johnson and Johnson logo is seen at an office building in Singapore

BOSTON (Reuters) - A Johnson & Johnson unit will pay the U.S. government $360 million to resolve an investigation into its financial support of a charity that helped Medicare patients cover out-of-pocket drug costs, the Justice Department said on Thursday.

The settlement with Actelion Pharmaceuticals US Inc, which became a subsidiary of J&J following a 2017 acquisition, was the largest so far to result from an industry-wide probe into drugmakers' support of patient assistance charities.

The government said Actelion from 2014 to 2015 used a charity as a conduit to improperly pay the co-pay obligations of thousands of Medicare patients using its pulmonary artery hypertension treatments Tracleer, Ventavis, Veletri and Opsumit.

That charity, Caring Voice Coalition (CVC), has stopped providing aid after the government in 2017 revoked its approval to do so because of concerns drugmakers had improper influence over it.

Actelion did not admit wrongdoing. Caroline Pavis, a company spokeswoman, in a statement said the conduct pre-dated New Brunswick, New Jersey-based J&J's acquisition of Actelion and that it was committed to following the law.

Richmond, Virginia-based CVC said it cannot comment on "ongoing legal matters."

Drug companies are prohibited from subsidizing co-payments for patients enrolled in the Medicare government healthcare program for the elderly. But companies may donate to non-profits providing co-pay assistance as long as they are independent.

Amid increased attention on rising drug prices in the United States, there has been concern that donations from drugmakers to patient-assistance groups may be contributing to price inflation.

A probe led by the U.S. Attorney's Office for the District of Massachusetts has led to allegations that several drugmakers used these charitable foundations as a means to pay Medicare patients' co-pays in violation of the Anti-Kickback Statute.

In Actelion's case, the government said it routinely obtained data from CVC regarding the extent that patients it helped used its drugs. Actelion then used that information to budget for future payments to the charity.

CVC was at the center of an earlier, $210 million settlement by United Therapeutics Corp in December 2017, which resolved claims the company improperly used the charity to cover co-payments.

Several other drugmakers have, since 2015, disclosed receiving subpoenas related to the investigation. Pfizer Inc in May resolved similar allegations involving a different charity for nearly $23.85 million.

Jazz Pharmaceuticals Plc and Lundbeck earlier this year disclosed they had reached agreements to resolve similar claims for $57 million and $52.6 million, respectively.

(Reporting by Nate Raymond in Boston; Editing by Bernadette Baum and Grant McCool)

By Nate Raymond

Stocks mentioned in the article
ChangeLast1st jan.
GILEAD SCIENCES -1.16% 67.35 Delayed Quote.-5.99%
H. LUNDBECK 2.54% 291.4 Delayed Quote.-9.97%
JAZZ PHARMACEUTICALS PLC 0.92% 142.1 Delayed Quote.5.53%
JOHNSON & JOHNSON 0.50% 147.84 Delayed Quote.5.81%
NOVARTIS -0.64% 86.96 Delayed Quote.6.21%
PFIZER 0.93% 44.57 Delayed Quote.21.92%
REGENERON PHARMACEUTICALS 0.15% 378.51 Delayed Quote.0.68%
UNITED THERAPEUTICS CORPORATION -1.66% 110.15 Delayed Quote.-25.55%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news "Economy & Forex"
02:01pSwiss cabinet approves text of trade deal with Britain after Brexit
RE
02:01pChina says to halt additional tariffs on U.S.-made cars from Jan. 1
RE
01:54pInsolvent Air Berlin's administrator sues Etihad for up 2 billion euros
RE
01:50pNOC NATIONAL OIL : and BPMC launch comprehensive plan to deliver fuel and fight smuggling in the south
PU
01:47pWeak economic data send world stocks tumbling
RE
01:45pWeak economic data send world stocks tumbling
RE
01:45pWeak economic data send world stocks tumbling
RE
01:40pMINISTRY OF FINANCE OF REPUBLIC OF INDIA : Goods and Services Tax (GST) evasion
PU
01:40pMINISTRY OF FINANCE OF REPUBLIC OF INDIA : Growth Rate of GDP
PU
01:35pSWISS FEDERAL COUNCIL : Federal Council lays the foundation for future economic and trade relations with the United Kingdom
PU
Latest news "Economy & Forex"
Advertisement